These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 7624119

  • 1. Wild type PAX3 protein and the PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma contain potent, structurally distinct transcriptional activation domains.
    Bennicelli JL, Fredericks WJ, Wilson RB, Rauscher FJ, Barr FG.
    Oncogene; 1995 Jul 06; 11(1):119-30. PubMed ID: 7624119
    [Abstract] [Full Text] [Related]

  • 2. Mechanism for transcriptional gain of function resulting from chromosomal translocation in alveolar rhabdomyosarcoma.
    Bennicelli JL, Edwards RH, Barr FG.
    Proc Natl Acad Sci U S A; 1996 May 28; 93(11):5455-9. PubMed ID: 8643596
    [Abstract] [Full Text] [Related]

  • 3. The alveolar rhabdomyosarcoma PAX3/FKHR fusion protein is a transcriptional activator.
    Sublett JE, Jeon IS, Shapiro DN.
    Oncogene; 1995 Aug 03; 11(3):545-52. PubMed ID: 7630639
    [Abstract] [Full Text] [Related]

  • 4. The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3.
    Fredericks WJ, Galili N, Mukhopadhyay S, Rovera G, Bennicelli J, Barr FG, Rauscher FJ.
    Mol Cell Biol; 1995 Mar 03; 15(3):1522-35. PubMed ID: 7862145
    [Abstract] [Full Text] [Related]

  • 5. Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma.
    Barr FG.
    Oncogene; 2001 Sep 10; 20(40):5736-46. PubMed ID: 11607823
    [Abstract] [Full Text] [Related]

  • 6. A genetic analysis of PAX3-FKHR, the oncogene of alveolar rhabdomyosarcoma.
    Kempf BE, Vogt PK.
    Cell Growth Differ; 1999 Dec 10; 10(12):813-8. PubMed ID: 10616906
    [Abstract] [Full Text] [Related]

  • 7. PAX3 and PAX7 exhibit conserved cis-acting transcription repression domains and utilize a common gain of function mechanism in alveolar rhabdomyosarcoma.
    Bennicelli JL, Advani S, Schäfer BW, Barr FG.
    Oncogene; 1999 Jul 29; 18(30):4348-56. PubMed ID: 10439042
    [Abstract] [Full Text] [Related]

  • 8. Fusion genes resulting from alternative chromosomal translocations are overexpressed by gene-specific mechanisms in alveolar rhabdomyosarcoma.
    Davis RJ, Barr FG.
    Proc Natl Acad Sci U S A; 1997 Jul 22; 94(15):8047-51. PubMed ID: 9223312
    [Abstract] [Full Text] [Related]

  • 9. An engineered PAX3-KRAB transcriptional repressor inhibits the malignant phenotype of alveolar rhabdomyosarcoma cells harboring the endogenous PAX3-FKHR oncogene.
    Fredericks WJ, Ayyanathan K, Herlyn M, Friedman JR, Rauscher FJ.
    Mol Cell Biol; 2000 Jul 22; 20(14):5019-31. PubMed ID: 10866659
    [Abstract] [Full Text] [Related]

  • 10. Hormone-dependent tumor regression in vivo by an inducible transcriptional repressor directed at the PAX3-FKHR oncogene.
    Ayyanathan K, Fredericks WJ, Berking C, Herlyn M, Balakrishnan C, Gunther E, Rauscher FJ.
    Cancer Res; 2000 Oct 15; 60(20):5803-14. PubMed ID: 11059777
    [Abstract] [Full Text] [Related]

  • 11. Transcriptional regulation of IGF-I receptor gene expression by the PAX3-FKHR oncoprotein.
    Ayalon D, Glaser T, Werner H.
    Growth Horm IGF Res; 2001 Oct 15; 11(5):289-97. PubMed ID: 11735247
    [Abstract] [Full Text] [Related]

  • 12. Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma.
    Galili N, Davis RJ, Fredericks WJ, Mukhopadhyay S, Rauscher FJ, Emanuel BS, Rovera G, Barr FG.
    Nat Genet; 1993 Nov 15; 5(3):230-5. PubMed ID: 8275086
    [Abstract] [Full Text] [Related]

  • 13. PAX3/forkhead homolog in rhabdomyosarcoma oncoprotein activates glucose transporter 4 gene expression in vivo and in vitro.
    Armoni M, Quon MJ, Maor G, Avigad S, Shapiro DN, Harel C, Esposito D, Goshen Y, Yaniv I, Karnieli E.
    J Clin Endocrinol Metab; 2002 Nov 15; 87(11):5312-24. PubMed ID: 12414908
    [Abstract] [Full Text] [Related]

  • 14. The role of chimeric paired box transcription factors in the pathogenesis of pediatric rhabdomysarcoma.
    Barr FG.
    Cancer Res; 1999 Apr 01; 59(7 Suppl):1711s-1715s. PubMed ID: 10197585
    [Abstract] [Full Text] [Related]

  • 15. Analysis of the transforming and growth suppressive activities of the PAX3-FKHR oncoprotein.
    Xia SJ, Barr FG.
    Oncogene; 2004 Sep 09; 23(41):6864-71. PubMed ID: 15286710
    [Abstract] [Full Text] [Related]

  • 16. Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma.
    Davis RJ, D'Cruz CM, Lovell MA, Biegel JA, Barr FG.
    Cancer Res; 1994 Jun 01; 54(11):2869-72. PubMed ID: 8187070
    [Abstract] [Full Text] [Related]

  • 17. Structural and functional studies of FKHR-PAX3, a reciprocal fusion gene of the t(2;13) chromosomal translocation in alveolar rhabdomyosarcoma.
    Hu Q, Yuan Y, Wang C.
    PLoS One; 2013 Jun 01; 8(6):e68065. PubMed ID: 23799156
    [Abstract] [Full Text] [Related]

  • 18. The oncogenic potential of the Pax3-FKHR fusion protein requires the Pax3 homeodomain recognition helix but not the Pax3 paired-box DNA binding domain.
    Lam PY, Sublett JE, Hollenbach AD, Roussel MF.
    Mol Cell Biol; 1999 Jan 01; 19(1):594-601. PubMed ID: 9858583
    [Abstract] [Full Text] [Related]

  • 19. Structural analysis of PAX3 genomic rearrangements in alveolar rhabdomyosarcoma.
    Barr FG, Nauta LE, Hollows JC.
    Cancer Genet Cytogenet; 1998 Apr 01; 102(1):32-9. PubMed ID: 9530337
    [Abstract] [Full Text] [Related]

  • 20. Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome?
    Anderson J, Gordon T, McManus A, Mapp T, Gould S, Kelsey A, McDowell H, Pinkerton R, Shipley J, Pritchard-Jones K, UK Children's Cancer Study Group (UKCCSG) and the UK Cancer Cytogenetics Group.
    Br J Cancer; 2001 Sep 14; 85(6):831-5. PubMed ID: 11556833
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.